Mitomycin-c Application for PRK

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the safety and efficacy of 5 seconds mitomycin-C (MMC) application during photorefractive keratectomy (PRK) for patients with low myopia.

• Phase: N/A

Details

• Lead Sponsor: Shahid Beheshti University of Medical Sciences
• Treatments: Mitomycin; Mitomycins

Criteria

Inclusion Criteria:

• The inclusion criteria was ablation depth less than 65 µm,

• a stable refractive error for at least 1 year

• corrected distance visual acuity (CDVA) of 0.1 LogMAR or better.

Exclusion Criteria:

• Patients with keratoconus suspect,

• excessive dry eyes,

• impaired wound healing processes,

• lenticular changes,

• corneal dystrophy,

• history of ocular surgery,

• anterior or posterior uveitis,

• glaucoma and retinal diseases were excluded.